Missouri’s highest court docket on Tuesday refused to contemplate Johnson & Johnson’s enchantment of a $2.12 billion (£1.63 billion) damages award to ladies who blamed their ovarian most cancers on asbestos in its child powder and different talc merchandise.
The Missouri Supreme Court docket let stand a June 23 resolution by a state appeals court docket, which upheld a jury’s July 2018 discovering of legal responsibility however diminished J&J’s payout from $4.69 billion after dismissing claims by a number of the 22 plaintiffs.
Johnson & Johnson stated it plans to enchantment to the U.S. Supreme Court docket.
It stated the decision was the product of a “essentially flawed trial, grounded in a defective presentation of the info,” and was “at odds with a long time of impartial scientific evaluations confirming Johnson’s Child Powder is protected, doesn’t comprise asbestos and doesn’t trigger most cancers.”
Kevin Parker, a lawyer for the plaintiffs, stated in a press release: “Johnson & Johnson ought to settle for the findings of the jury and the appellate court docket and transfer ahead with correct compensation to the victims.”
Johnson & Johnson stated in Could it will cease promoting its Child Powder talc in america and Canada.
The New Brunswick, New Jersey-based firm stated final month it faces greater than 21,800 lawsuits claiming that its talc merchandise trigger most cancers due to contamination from asbestos, a recognized carcinogen.
In its June resolution, the Missouri Court docket of Appeals stated it was affordable to deduce from the proof that Johnson & Johnson “disregarded the protection of customers” in its drive for revenue, regardless of figuring out its talc merchandise brought about ovarian most cancers. It additionally discovered “important reprehensibility” within the firm’s conduct.
Johnson & Johnson has confronted intense scrutiny of its child powder’s security following a 2018 Reuters investigative report that discovered it knew for many years that asbestos lurked in its talc.
Inner firm data, trial testimony and different proof present that from no less than 1971 to the early 2000s, J&J’s uncooked talc and completed powders typically examined optimistic for small quantities of asbestos. (https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/)
Johnson & Johnson shares have been up 2 cents at $138.71 in late afternoon buying and selling on the New York Inventory Alternate.
Disclaimer: This put up has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor